ALAMEDA, Calif – BioTime, Inc. (NYSE Amex:BTIM) announced today that its Chief Financial Officer, Steven A. Seinberg, has resigned his position effective September 17, 2010. Mr. Seinberg, who is an attorney, will be returning to the practice of law at a private firm. Mr. Seinberg has agreed to assist BioTime in transition tasks on a […]
Sigma Life Science launches range of engineered cell lines exploiting CompoZr(R) zinc finger nuclease technology St. Louis – Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich(R) Corporation (Nasdaq: SIAL), today announced the global release of a pioneering range of engineered mammalian cell lines. This new product range combines Sigma’s proprietary […]
Since April 2009, ReproCELL has been manufacturing iPS cell-derived cardiomyocytes for drug toxicity testing as the world’s first drug discovery support business provider founded on iPS cells. The prospective new offering of neuronal cells is the second line of products to be introduced by the company, and is a considerable expansion of their scope of […]
Madison, Wisconsin – Promega Corporation announces it will provide FuGENE® HD Transfection Reagent throughout the life science market. The comprehensive, direct use offering from Promega means any life scientist can utilize FuGENE technology with no licensing requirements. FuGENE HD enables the transfection of DNA into many cell types with high efficiency and little-to-no toxicity. FuGENE […]
Shepshed, LEICS., UK – The thermo-reversible mountant CyGEL™ (Biostatus Ltd., UK) enables high resolution imaging of live 3D tumor spheroids cultured in low-adherence conditions and without fixation or cytospin centrifugation. A recent paper by Fredika M. Robertson, et al., Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Cell Phenotype. J Biomol Screen. […]
Accelerating R&D of regenerative medicine*1 materials to promote business application FUJIFILM Corporation (President and CEO: Shigetaka Komori) has decided to accept the third-party allocation of new shares worth 4 billion yen from Japan Tissue Engineering Co., Ltd.(President: Yosuke Ozawa; “J-TEC” hereinafter), the provider of tissue-engineered regenerative medical materials in Japan. After the allocation, Fujifilm is […]
OCEANSIDE, CA – International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO’s therapeutic programs using its human parthenogenetic stem cells. According to ISCO’s Chairman Ken Aldrich, “Because we have never […]
BioTime, Inc. (NYSE Amex: BTIM) announced today that it will launch seven new human embryonic progenitor cell lines and seven novel culture media for these lines on September 1, 2010. These progenitor lines were produced from embryonic stem cells using the Company’s ACTCellerateTM technology. Human embryonic progenitor cells are intermediate in the developmental process between […]
Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox®. Supporting the new service is an additional 90 square metres of laboratory space at Cyprotex’s Macclesfield, UK facility housing the latest technology in multi-parametric automated fluorescent imaging and cellular analysis. This gives […]
Axiogenesis AG and iPS Academia Japan Inc. (Kyoto, Japan) announced that they have executed a non-exclusive agreement with iPS Academia (Kyoto, Japan) through which Axiogenesis obtains worldwide access to the extensive portfolio of induced pluripotent stem cell (“iPSC”) technology for iPSC-derived cardiomyocytes and other cell types, pioneered by Professor Shinya Yamanaka, Center for iPS Cell […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
